Intelligence Login
Inventor Portal
  • Why PatentVest?
  • Our Solution
  • Case Studies
  • About
    • About Us
    • Our Team
    • Our Track Record
  • News & Media
    • Reports
    • Videos
    • Articles
    • Legal Articles
    • Press Releases
  • Contact Us
  • Inventor Portal
  • Intelligence Login
Contact

MDB Capital Holdings Announces Third MDB-Launched Company to Achieve FDA Approval

by Staff | Nov 29, 2022 | Press Releases

DALLAS, T.X. / ACCESSWIRE / November 29, 2022 / MDB Capital Holdings, LLC, a privately-held public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today announced that...

Public Ventures LLC Completes First Public Company Financing as a Broker-Dealer for Cue Biopharma, Inc. (Nasdaq:CUE)

by Staff | Nov 17, 2022 | Press Releases

DALLAS, TX / ACCESSWIRE / November 17, 2022 / Public Ventures, LLC, a wholly owned subsidiary of MDB Capital Holdings, LLC, completed its first financing as a broker-dealer for Cue Biopharma, Inc. (NASDAQ:CUE). The Public Ventures’ portion of the financing was...

MDB Capital Holdings Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq

by Staff | Nov 11, 2022 | Press Releases

DALLAS, TX / ACCESSWIRE / November 11, 2022 / MDB Capital Holdings, LLC (“MDB”), a privately-held public venture platform with the objective of growing the public venture marketplace and optimizing the way meaningful technologies are financed and built, today...

Recent Posts

  • The Muscle Problem: How Myostatin Could Expand the GLP-1 Opportunity
  • The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market.
  • From Patent Risk to Strategic Clarity: How Docana Built an IP Strategy with PatentVest
  • Using AI In Your Inventive Process? Proceed to Patent, But Carefully
  • The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine

Recent Comments

    Archives

    • June 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • October 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • February 2024
    • January 2024
    • November 2023
    • October 2023
    • June 2023
    • May 2023
    • November 2022
    • October 2022
    • August 2022
    • July 2022
    • June 2022

    Categories

    • Case Studies
    • Legal Reports
    • PatentVest Pulse
    • Press Releases
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Why PatentVest?Our SolutionAboutNews & Media

    Terms of Use  |       © 2026 – PatentVest, Inc.

    • Follow